Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,292 | -24,862 | -13,071 | -4,280 | -10,284 |
| Depreciation Amortization | 3,407 | 1,956 | 867 | 233 | 1,311 |
| Income taxes - deferred | -8,736 | 0 | N/A | N/A | N/A |
| Accounts receivable | -4,631 | -6,087 | -5,275 | -1,558 | 1,663 |
| Accounts payable and accrued liabilities | -182 | 673 | -683 | -40 | 169 |
| Other Working Capital | -4,102 | -8,086 | -7,613 | -4,530 | 9,148 |
| Other Operating Activity | 26,553 | 20,204 | 15,706 | 6,544 | 7,858 |
| Operating Cash Flow | $-18,983 | $-16,202 | $-10,069 | $-3,631 | $9,865 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,473 | -2,584 | -1,661 | -750 | -4,748 |
| Net Acquisitions | -63,184 | -33,184 | -33,184 | N/A | N/A |
| Investing Cash Flow | $-66,657 | $-35,768 | $-34,845 | $-750 | $-4,748 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | 0 | N/A | N/A | -27,359 |
| Common Stock Issued | 6,546 | 5,631 | 3,737 | 1,510 | 333,249 |
| Other Financing Activity | -1,117 | -336 | -336 | 0 | 0 |
| Financing Cash Flow | $5,421 | $5,295 | $3,401 | $1,510 | $305,890 |
| Beginning Cash Position | 409,852 | 409,852 | 409,852 | 409,852 | 98,845 |
| End Cash Position | 329,633 | 363,177 | 368,339 | 406,981 | 409,852 |
| Net Cash Flow | $-80,219 | $-46,675 | $-41,513 | $-2,871 | $311,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,983 | -16,202 | -10,069 | -3,631 | 9,865 |
| Capital Expenditure | -3,483 | -2,590 | -1,663 | -750 | -4,751 |
| Free Cash Flow | -22,466 | -18,792 | -11,732 | -4,381 | 5,114 |